These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


298 related items for PubMed ID: 27821445

  • 1. Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model.
    Landersdorfer CB, Nguyen TH, Lieu LT, Nguyen G, Bischof RJ, Meeusen EN, Li J, Nation RL, McIntosh MP.
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821445
    [Abstract] [Full Text] [Related]

  • 2. Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.
    Boisson M, Jacobs M, Grégoire N, Gobin P, Marchand S, Couet W, Mimoz O.
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7331-9. PubMed ID: 25267660
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of nebulized colistin methanesulfonate in critically ill patients.
    Boisson M, Grégoire N, Cormier M, Gobin P, Marchand S, Couet W, Mimoz O.
    J Antimicrob Chemother; 2017 Sep 01; 72(9):2607-2612. PubMed ID: 28575278
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW, Zhou QT, Cheah SE, Zhao J, Chen K, Wang J, Chan HK, Li J.
    Antimicrob Agents Chemother; 2017 Mar 01; 61(3):. PubMed ID: 28031207
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale.
    Grégoire N, Mimoz O, Mégarbane B, Comets E, Chatelier D, Lasocki S, Gauzit R, Balayn D, Gobin P, Marchand S, Couet W.
    Antimicrob Agents Chemother; 2014 Dec 01; 58(12):7324-30. PubMed ID: 25267662
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.
    Jitmuang A, Nation RL, Koomanachai P, Chen G, Lee HJ, Wasuwattakul S, Sritippayawan S, Li J, Thamlikitkul V, Landersdorfer CB.
    J Antimicrob Chemother; 2015 Dec 01; 70(6):1804-11. PubMed ID: 25698772
    [Abstract] [Full Text] [Related]

  • 11. Aerosol therapy with colistin methanesulfonate: a biopharmaceutical issue illustrated in rats.
    Marchand S, Gobin P, Brillault J, Baptista S, Adier C, Olivier JC, Mimoz O, Couet W.
    Antimicrob Agents Chemother; 2010 Sep 01; 54(9):3702-7. PubMed ID: 20547787
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis.
    Koomanachai P, Landersdorfer CB, Chen G, Lee HJ, Jitmuang A, Wasuwattakul S, Sritippayawan S, Li J, Nation RL, Thamlikitkul V.
    Antimicrob Agents Chemother; 2014 Sep 01; 58(1):440-6. PubMed ID: 24189256
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys.
    Marchand S, Bouchene S, de Monte M, Guilleminault L, Montharu J, Cabrera M, Grégoire N, Gobin P, Diot P, Couet W, Vecellio L.
    Pharm Res; 2015 Oct 01; 32(10):3403-14. PubMed ID: 26040660
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.
    Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K.
    J Antimicrob Chemother; 2004 May 01; 53(5):837-40. PubMed ID: 15044428
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.
    Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, Karaiskos I, Poulakou G, Kontopidou F, Armaganidis A, Cars O, Giamarellou H.
    Antimicrob Agents Chemother; 2009 Aug 01; 53(8):3430-6. PubMed ID: 19433570
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.